Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Findlow

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Expert Review of Vaccines|September 28, 2023
National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal diseaseCynthia Burman, Jamie Findlow, Helen S Marshall, et al.
Expert Review of Vaccines|July 21, 2021
Correlates of protection for meningococcal surface protein vaccines: lessons from the pastJamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 21, 2013
Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccineJohannes Elias, Jamie Findlow, Ray Borrow, et al.
Expert Review of Vaccines|August 3, 2007
Neisseria vaccines 2007Jamie Findlow, Paul Balmer, Daniel Yero, et al.
Clinical and Vaccine Immunology : CVI|March 9, 2007
Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assayJamie Findlow, Ann Holland, Diana Martin, et al.
Epidemiology and Infection|April 13, 2023
Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature reviewCarmen Pardo de Santayana, Myint Tin Tin Htar, Jamie Findlow, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 21, 2022
Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017Charles Nuttens, Jamie Findlow, Paul Balmer, et al.
Frontiers in Microbiology|November 26, 2020
Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal IsolatesPaul Liberator, Robert G K Donald, Paul Balmer, et al.
Vaccine|September 4, 2020
Broad vaccine protection against Neisseria meningitidis using factor H binding proteinJamie Findlow, Christopher D Bayliss, Peter T Beernink, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding proteinJay Lucidarme, Lionel Tan, Rachel M Exley, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Expert Review of Vaccines|September 28, 2023
National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal diseaseCynthia Burman, Jamie Findlow, Helen S Marshall, et al.
Expert Review of Vaccines|July 21, 2021
Correlates of protection for meningococcal surface protein vaccines: lessons from the pastJamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 21, 2013
Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccineJohannes Elias, Jamie Findlow, Ray Borrow, et al.
Expert Review of Vaccines|August 3, 2007
Neisseria vaccines 2007Jamie Findlow, Paul Balmer, Daniel Yero, et al.
Clinical and Vaccine Immunology : CVI|March 9, 2007
Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assayJamie Findlow, Ann Holland, Diana Martin, et al.
Epidemiology and Infection|April 13, 2023
Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature reviewCarmen Pardo de Santayana, Myint Tin Tin Htar, Jamie Findlow, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 21, 2022
Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017Charles Nuttens, Jamie Findlow, Paul Balmer, et al.
Frontiers in Microbiology|November 26, 2020
Commentary: Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal IsolatesPaul Liberator, Robert G K Donald, Paul Balmer, et al.
Vaccine|September 4, 2020
Broad vaccine protection against Neisseria meningitidis using factor H binding proteinJamie Findlow, Christopher D Bayliss, Peter T Beernink, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2011
Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding proteinJay Lucidarme, Lionel Tan, Rachel M Exley, et al.
Pageof 10